Form 10-Q · Quarterly report
McKesson Corporation 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0000927653
- Accession no.
- 0000927653-26-000234
Summary
McKesson Corporation reported an 8% year-over-year increase in revenue to $105.38 billion and a decline in diluted earnings per share to $5.15 from $6.25 for the quarter ended June 30, 2026. The company also disclosed Apollo Global Management funds' approximately $1.25 billion investment for about a 13% minority stake in its Medical-Surgical Solutions segment, a new four-segment reporting structure, a $5.0 billion share repurchase authorization, and a quarterly dividend increase to $0.94 per share.
Key points
- Revenues rose 8% to $105.38 billion and gross profit rose 12% for the quarter ended June 30, 2026, while net income attributable to McKesson fell 22% to $614 million.
- McKesson implemented a new segment structure with four reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
- Apollo Funds invested about $1.25 billion for convertible preferred equity representing roughly 13% of McKesson's Medical-Surgical Solutions segment, which McKesson intends to separate into an independent company.
- McKesson's board approved an additional $5.0 billion share repurchase authorization and raised the quarterly dividend from $0.82 to $0.94 per share.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Summary 35 Trends and Uncertainties 36 Overview of Consolidated Results 37 Overview of Segment Results 41 New Accounting Pronouncements 43 Financial Condition, Liquidity, and Capital Resources 44 Cautionary Notice About Forward-Looking Statements 48 Available Information 48 GENERAL Management’s discussion and analysis of financial condition and results of operations, referred to as the “Financial Review,” is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the “Company,”…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.